Department of Cardiology, Second Affiliated Hospital of Naval Medical University, Shanghai Cardiovascular Institute of Integrative Medicine, Shanghai, China; Department of Experimental Medical Science, Lund University, Sweden.
Department of Clinical Sciences Malmö, Lund University, Sweden.
Pharmacol Res. 2024 Jul;205:107259. doi: 10.1016/j.phrs.2024.107259. Epub 2024 Jun 11.
The osteopontin-derived peptide FOL-005 stimulates hair growth. Using ligand-receptor glyco-capture technology we identified neuropilin-1 (NRP-1), a known co-receptor for vascular endothelial growth factor (VEGF) receptors, as the most probable receptor for FOL-005 and the more stable analogue FOL-026. X-ray diffraction and microscale thermophoresis analysis revealed that FOL-026 shares binding site with VEGF in the NRP-1 b1-subdomain. Stimulation of human umbilical vein endothelial cells with FOL-026 resulted in phosphorylation of VEGFR-2, ERK1/2 and AKT, increased cell growth and migration, stimulation of endothelial tube formation and inhibition of apoptosis in vitro. FOL-026 also promoted angiogenesis in vivo as assessed by subcutaneous Matrigel plug and hind limb ischemia models. NRP-1 knock-down or treatment of NRP-1 antagonist EG00229 blocked the stimulatory effects of FOL-026 on endothelial cells. Exposure of human coronary artery smooth muscle cells to FOL-026 stimulated cell growth, migration, inhibited apoptosis, and induced VEGF gene expression and VEGFR-2/AKT phosphorylation by an NRP-1-dependent mechanism. RNA sequencing showed that FOL-026 activated pathways involved in tissue repair. These findings identify NRP-1 as the receptor for FOL-026 and show that its biological effects mimic that of growth factors binding to the VEGF receptor family. They also suggest that FOL-026 may have therapeutical potential in conditions that require vascular repair and/or enhanced angiogenesis.
骨桥蛋白衍生肽 FOL-005 可刺激毛发生长。我们使用配体-受体糖捕获技术鉴定出神经纤毛蛋白-1(NRP-1),它是血管内皮生长因子(VEGF)受体的已知共受体,是 FOL-005 和更稳定类似物 FOL-026 的最可能的受体。X 射线衍射和微尺度热泳分析表明,FOL-026 在 NRP-1 b1 亚结构域与 VEGF 共享结合位点。FOL-026 刺激人脐静脉内皮细胞导致 VEGFR-2、ERK1/2 和 AKT 的磷酸化,增加细胞生长和迁移,刺激内皮管形成,并抑制体外细胞凋亡。FOL-026 还通过皮下 Matrigel plugs 和后肢缺血模型在体内促进血管生成。NRP-1 敲低或 NRP-1 拮抗剂 EG00229 治疗阻断了 FOL-026 对内皮细胞的刺激作用。FOL-026 暴露于人冠状动脉平滑肌细胞中可刺激细胞生长、迁移、抑制凋亡,并通过 NRP-1 依赖的机制诱导 VEGF 基因表达和 VEGFR-2/AKT 磷酸化。RNA 测序显示,FOL-026 激活了涉及组织修复的途径。这些发现确定了 NRP-1 是 FOL-026 的受体,并表明其生物学效应模拟了与 VEGF 受体家族结合的生长因子。它们还表明,FOL-026 可能在需要血管修复和/或增强血管生成的情况下具有治疗潜力。